Abstracts of the 2023 Canadian Association of Medical Oncologists Annual Scientific Meeting

Alexi Campbell; Sharlene Gill; Desiree Hao; Erin Powell; Stephanie Snow; Zachary Veitch; Stephen Welch

doi:10.3390/curroncol30080550

Abstracts of the 2023 Canadian Association of Medical Oncologists Annual Scientific Meeting

Curr Oncol. 2023 Aug 11;30(8):7581-7607. doi: 10.3390/curroncol30080550.

Authors

Alexi Campbell¹, Sharlene Gill¹, Desiree Hao¹, Erin Powell¹, Stephanie Snow¹, Zachary Veitch¹, Stephen Welch¹

Affiliation

¹ Canadian Association of Medical Oncologists, Ottawa, ON K1E 3R9, Canada.

Abstract

On behalf of the Canadian Association of Medical Oncologists, we are pleased to present the abstracts of the 2023 Annual Scientific Meeting. The CAMO Annual Scientific Meeting (ASM) took place on 27 April 2023 in an in-person event in Toronto, ON. Thirty-two (32) abstracts were selected for presentation as oral presentations, in-person poster presentations, and virtual poster presentations. Awards for the top four (4) abstracts were presented during the ASM; they have been marked as "Award Recipient". We congratulate all presenters on their research work and contribution.

Keywords: cancer; medical oncology; research.

Publication types

Congress

MeSH terms

Canada
Humans
Oncologists*

Grants and funding

Educational grants provided to support the conference by the following companies: Bristol-Myers Squibb Canada Co., Advanced Accelerator Applications Canada Inc., Amgen Canada Inc., EMD Serono/Pfizer, Novartis Canada, Pfizer Canada ULC, AstraZeneca Canada, Boehringer-Ingelheim (Canada) Ltd., Gilead Sciences Canada, Inc., Kite, Abbvie Corporation, Astellas Pharma Canada Inc., Eisai Limited, EMREACH Inc., Ipsen Biopharmaceuticals Canada, Inc., Janssen Inc., LifeLabs, Novocure, Merck Canada Inc., Seagen Canada Inc.